The latest biotech news - Labiotech.eu

Home News and Trends

Latest Posts

Trump’s healthcare cabinet picks: Implications for U.S. biopharma

News and Trends 29 Nov 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?

November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

Evotec acquisition

News and Trends 25 Nov 2024

Evotec on the brink of acquisition: At what cost for the biotech industry?

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape.

November 25, 2024 - 8 minutesmins - By Jules Adam

Biotech partnership deals in October

News and Trends 4 Nov 2024

Top biotech deals of October 2024

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

Halloween biotech fears

News and Trends 31 Oct 2024

Halloween biotech stories: Unveiling scientists’ worst fears

What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.

October 31, 2024 - 15 minutesmins - By Jules Adam

Dravet syndrome new treatment

News and Trends 24 Oct 2024

Fighting severe epilepsies: A new era for Dravet syndrome treatment?

Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.

October 24, 2024 - 10 minutesmins - By Jules Adam

RNA editing

News and Trends 23 Oct 2024

RNA editing in humans: the race begins with first successful trial

Wave Life Sciences achieves RNA editing in the clinic, crossing a major milestone in the space.

October 23, 2024 - 6 minutesmins - By Roohi Mariam Peter

ADVERTISEMENT

cellular reprogramming with Shift Bioscience

News and Trends 21 Oct 2024

Turning back time with cellular reprogramming: Shift raises $16 million in seed funding

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.

October 21, 2024 - 9 minutesmins - By Jules Adam

20S proteasome activation: Berlin biotech Booster Therapeutics secures $15 million for innovative therapies to tackle neurodegenerative diseases

News and Trends 15 Oct 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.

October 15, 2024 - 6 minutesmins - By Jules Adam

Biotech IPO

News and Trends 10 Oct 2024

Second biotech IPO boom of the year: what does it mean for the industry?

Discover why biotech is experiencing a second IPO boom in 2024 and what it means for the broader industry.

October 10, 2024 - 9 minutesmins - By Monica Karpinski

resolution therapeutics

News and Trends 3 Oct 2024

Resolution Therapeutics raises $85 million to advance its macrophage therapy

Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.

October 3, 2024 - 7 minutesmins - By Jules Adam

Niemenn Pick disease

News and Trends 2 Oct 2024

Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

October 2, 2024 - 7 minutesmins - By Willow Shah-Neville

bird flu vaccines

News and Trends 30 Sep 2024

The race for a bird flu vaccine: milestones and breakthroughs

The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.

September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter

ADVERTISEMENT